Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash Flows From Operating Activities:
Net loss	$ (3,250,711)	$ (1,098,461)
Adjustments to reconcile net loss to cash used in operating activities:
Extinguishment of note payable		233,240
Accrued interest		28,519
Change in fair value of warrant liability	(3,813,000)
Stock-based compensation	3,591,565
Inducement expense	298,714
Amortization of intangible assets	136,640
Change in operating assets and liabilities:
Prepaid expenses and other current assets	(66,208)	(49,588)
Accounts payable and accrued liabilities	(59,278)	(7,632)
Net cash used in operating activities	(3,162,278)	(893,922)
Cash Flows From Investing Activities:
Purchase of license agreement	(675,000)
Net cash used in investing activities	(675,000)
Cash Flows From Financing Activities:
Proceeds from sale of common stock, net of offering costs	21,614,488
Proceeds from convertible notes payable		50,000
Proceeds from note payable		1,319,910
Repayment of note payable		(157,714)
Proceeds from warrant exercises	3,267,245	1,212,196
Net cash provided by financing activities	24,881,733	(107,714)
Effect of foreign exchange rate on cash	34,235	(86,677)
Net increase in cash	21,078,690	231,597
Cash - beginning of period	1,578,460	43,714
Cash - end of period	22,657,150	275,311
Supplemental non-cash financing activities:
Warrants issued in conjunction with notes payable issuances		17,851
Shares of common stock issued for note payable extensions		32,149
Shares of common stock issued for accounts payable		$ 173,482